David S Snyder's Insider Trades & SAST Disclosures
David S Snyder's most recent trade in Pricesmart Inc. was a trade of 1,642 Common Stock, $0.0001 par value per share done . Disclosure was reported to the exchange on Feb. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David S Snyder.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pricesmart Inc. | David R. Snyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 1,642 | 9,147 (0%) | 0% | 0 | Common Stock, $0.0001 par value per share | |
| Coya Therapeutics Inc | David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 140,562 | 140,562 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | David S. Snyder | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.19 per share. | 14 Nov 2024 | 1,800 | 8,800 | - | 7.2 | 12,934 | Common Stock, par value $0.0001 per share |
| Coya Therapeutics Inc | David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,596 | 70,596 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Snyder David S. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 81,819 | 81,819 | - | - | Stock Option (right to buy) | |
| Pricesmart Inc. | R. Snyder David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 1,965 | 7,505 (0%) | 0% | 0 | Common Stock, $0.0001 par value per share | |
| Coya Therapeutics Inc | David S. Snyder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
| Pricesmart Inc. | David R. Snyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 2,234 | 5,540 (0%) | 0% | 0 | Common Stock, $0.0001 par value per share | |
| Pricesmart Inc. | David R. Snyder | Director | 12 Jan 2023 | 15 | 3,306 (0%) | 0% | 71.8 | 1,077 | Common Stock, $0.0001 par value per share | |
| Coya Therapeutics Inc | David S. Snyder | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 7,000 | 7,000 | - | - | Common Stock, par value $0.0001 per share | |
| Coya Therapeutics Inc | David S. Snyder | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 3,500 | 3,500 | - | - | Warrant to Purchase Common Stock | |
| Pricesmart Inc. | David R. Snyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 1,995 | 3,291 (0%) | 0% | 0 | Common Stock, $0.0001 par value per share | |
| Pricesmart Inc. | David R. Snyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 1,296 | 1,296 (0%) | 0% | 0 | Common Stock, $0.0001 par value per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges